dr. armstrong on detection of chromosomal defects in mcrpc
Published 4 years ago • 67 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:26
dr. armstrong on ar-v7 as a biomarker of response to taxane chemotherapy in mcrpc
-
1:19
dr. armstrong on the utility of liquid biopsies in mcrpc
-
1:38
dr. armstrong discusses findings of arches trial in prostate cancer
-
1:00
dr. armstrong on the utility of ar-v7 as a biomarker in prostate cancer
-
1:00
dr. armstrong on the utility of pamiparib and other parp inhibitors in prostate cancer
-
9:23
drs. armstrong, wallis on ai biomarkers and hrqol for localized prostate cancer, mcrpc
-
0:57
dr. armstrong on the utility of parp inhibitors in mutated prostate cancer
-
3:33
prophecy trial: ar-v7 ctcs as a biomarker in mcrpc
-
17:40
genetic testing for prostate cancer | brca | #markscholzmd #alexscholz #pcri
-
36:44
surgery or radiation or active surveillance - which should a prostate cancer patient choose?
-
25:31
genetic testing in advanced prostate cancer
-
0:56
dr. armstrong on sipuleucel-t in prostate cancer
-
1:01
dr. armstrong discusses ar-v7 testing in prostate cancer
-
1:20
dr. armstrong discusses hereditary prostate cancer
-
3:22
detection of ar-v7 in prostate cancer
-
1:18
dr. armstrong discusses arches trial in prostate cancer
-
4:19
the biology of prostate cancer
-
1:14
dr. armstrong on precision medicine for metastatic prostate cancer
-
1:28
vision: 177lu-psma-617 in psma-positive mcrpc
-
2:09
andrew armstrong, md, on determining treatment of prostate cancer with dna repair markers
-
9:53
dr. andrew armstrong on precision medicine approaches in advanced prostate cancer
-
1:05
is a simple blood test the key to catching osteomimicry in mcrpc?